Clanobutin

CAS : 30544-61-7

Ref. 3D-FBA54461

Informations sur le produit

• Nom: Clanobutin
• Synonymes: 4-((4-Chlorobenzoyl)(4-methoxyphenyl)amino)butanoic acid, 4-(p-Chloro-N-(p-methoxyphenyl)benzamido)butyric acid, B 6518, Brn 2172135, Butanoic acid, 4-((4-chlorobenzoyl)(4-methoxyphenyl)amino)- (9CI), Butanoic acid, 4-[(4-chlorobenzoyl)(4-methoxyphenyl)amino]-, Butyric acid, 4-(p-chloro-N-(p-methoxyphenyl)benzamido)-, Bykahepar, Clanobutin [INN], Clanobutina, Clanobutina [INN-Spanish], Clanobutine, Clanobutine [INN-French], Clanobutinum, Clanobutinum [INN-Latin], N-(p-Chlorbenzoyl)-gamma-(p-anisidino)-buttersaeure, N-(p-Chlorbenzoyl)-gamma-(p-anisidino)-buttersaeure [German], N-(p-Chlorobenzoyl)-gamma-(p-anisidino)butyric acid, N-(p-Chlorobenzoyl)-γ-(p-anisidino)butyric acid, Unii-W6Y945055S

Description

Clanobutin is a drug that has been shown to have an inhibitory effect on fatty acid synthesis. It is used in the treatment of bowel disease, such as inflammatory bowel disease. This drug also has a profile that includes symptoms of occlusive ileitis and colitis in animals. Clanobutin inhibits the production of inflammatory substances by interfering with the process of lipid synthesis.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 347.8 g/mol
• Formule: C₁₈H₁₈ClNO₄
• Degré de pureté: Min. 95%